Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation
…, W Zhuang, D Lu, B Zhou, B Liang, X Yue…
文献索引：Hu, Yun; Yang, Yaqi; Yu, Yanjun; Wen, Gesi; Shang, Nana; Zhuang, Wei; Lu, Dihan; Zhou, Binhua; Liang, Baoxia; Yue, Xin; Li, Feng; Du, Jun; Bu, Xianzhang Journal of Medicinal Chemistry, 2013 , vol. 56, # 15 p. 6033 - 6053
Alzheimer's disease (AD) is associated with impaired Aβ degradation in the brain. Enhancing the process of Aβ clearance is an attractive potential AD therapy. Treatment with LXR agonists may reduce Aβ levels in vivo. However, the clinical potential of many LXR agonists is limited because of their nonselective actions on LXRα/β, which lead to undesired hepatic lipogenesis via LXRα-dependent pathways. In this study, ABCA1 up-regulators ...
